{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T12:36:16Z","timestamp":1761482176784,"version":"build-2065373602"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,26]]},"DOI":"10.7759\/cureus.95437","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T12:32:12Z","timestamp":1761481932000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Atrial Fibrillation and Rapid Ventricular Response in a 22-Year-Old Athlete With Sickle Cell Trait"],"prefix":"10.7759","author":[{"given":"Tristan S","family":"Moseley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M","family":"Sasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan T","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D","family":"Overturf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Sickle cell trait","author":"Ashorobi D","year":"2025","unstructured":"Ashorobi D, Ramsey A, Killeen RB, Bhatt R. Sickle cell trait. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009202","article-title":"Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries","volume":"7","author":"Jiao B","year":"2023","unstructured":"Jiao B, Johnson KM, Ramsey SD, Bender MA, Devine B, Basu A. Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries. Blood Adv. 2023, 7:3276-83. 10.1182\/bloodadvances.2022009202","journal-title":"Blood Adv"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2025.102995","article-title":"Practical guidance for management of atrial fibrillation in sports cardiology","volume":"50","author":"Palermi A","year":"2025","unstructured":"Palermi A, Molinari LV, Ricci F, Gallina S, Renda G. Practical guidance for management of atrial fibrillation in sports cardiology. Curr Probl Cardiol. 2025, 50:102995. 10.1016\/j.cpcardiol.2025.102995","journal-title":"Curr Probl Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014119","article-title":"Where there is smoke, there is fire: afib in SCD","volume":"8","author":"Uniat J","year":"2024","unstructured":"Uniat J, Wood JC. Where there is smoke, there is fire: afib in SCD. Blood Adv. 2024, 8:5639-40. 10.1182\/bloodadvances.2024014119","journal-title":"Blood Adv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2019.04.010","article-title":"Association of sickle cell trait with atrial fibrillation: the REGARDS cohort","volume":"55","author":"Douce DR","year":"2019","unstructured":"Douce DR, Soliman EZ, Naik R, et al.. Association of sickle cell trait with atrial fibrillation: the REGARDS cohort. J Electrocardiol. 2019, 55:1-5. 10.1016\/j.jelectrocard.2019.04.010","journal-title":"J Electrocardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40798-018-0131-6","article-title":"Sickle cell trait and sudden death","volume":"4","author":"Mitchell BL","year":"2018","unstructured":"Mitchell BL. Sickle cell trait and sudden death. Sports Med Open. 2018, 4:19. 10.1186\/s40798-018-0131-6","journal-title":"Sports Med Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency","volume":"107","author":"Shlipak MG","year":"2003","unstructured":"Shlipak MG, Fried LF, Crump C, et al.. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003, 107:87-92. 10.1161\/01.cir.0000042700.48769.59","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.06.031","article-title":"Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study","volume":"158","author":"Watanabe H","year":"2009","unstructured":"Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J. 2009, 158:629-36. 10.1016\/j.ahj.2009.06.031","journal-title":"Am Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab279","article-title":"Radiofrequency ablation to achieve durable pulmonary vein isolation","volume":"24","author":"Mulder MJ","year":"2022","unstructured":"Mulder MJ, Kemme MJ, Allaart CP. Radiofrequency ablation to achieve durable pulmonary vein isolation. Europace. 2022, 24:874-86. 10.1093\/europace\/euab279","journal-title":"Europace"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2014.5502","article-title":"Exertional sickling: questions and controversy","volume":"6","author":"Blinder MA","year":"2014","unstructured":"Blinder MA, Russel S. Exertional sickling: questions and controversy. Hematol Rep. 2014, 6:5502. 10.4081\/hr.2014.5502","journal-title":"Hematol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2016.04.001","article-title":"Hyperchloremia - why and how","volume":"36","author":"Nagami GT","year":"2016","unstructured":"Nagami GT. Hyperchloremia - why and how. Nefrologia. 2016, 36:347-53. 10.1016\/j.nefro.2016.04.001","journal-title":"Nefrologia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar JA","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al.. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024, 149:e1-e156. 10.1161\/CIR.0000000000001193","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18829","article-title":"Diltiazem dosing strategies in the management of atrial fibrillation with rapid ventricular rate","volume":"13","author":"Bishop J Jr","year":"2021","unstructured":"Bishop J Jr, Akram G. Diltiazem dosing strategies in the management of atrial fibrillation with rapid ventricular rate. Cureus. 2021, 13:e18829. 10.7759\/cureus.18829","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000310","article-title":"2015 ACC\/AHA\/hrs guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society","volume":"133","author":"Page RL","year":"2016","unstructured":"Page RL, Joglar JA, Caldwell MA, et al.. 2015 ACC\/AHA\/hrs guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. Circulation. 2016, 133:e471-505. 10.1161\/CIR.0000000000000310","journal-title":"Circulation"},{"key":"ref15","article-title":"Synchronized electrical cardioversion","author":"Goyal A","year":"2025","unstructured":"Goyal A, Singh B, Chhabra L, Singhal M. Synchronized electrical cardioversion. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs314","article-title":"The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy","volume":"34","author":"Coppens M","year":"2013","unstructured":"Coppens M, Eikelboom JW, Hart RG, et al.. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. Eur Heart J. 2013, 34:170-6. 10.1093\/eurheartj\/ehs314","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.12.1447","article-title":"The role of echocardiography in atrial fibrillation and cardioversion","volume":"89","author":"Troughton RW","year":"2003","unstructured":"Troughton RW, Asher CR, Klein AL. The role of echocardiography in atrial fibrillation and cardioversion. Heart. 2003, 89:1447-54. 10.1136\/heart.89.12.1447","journal-title":"Heart"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4022\/jafib.499","article-title":"Apixaban in patients with atrial fibrillation: a systematic review","volume":"5","author":"Maan A","year":"2012","unstructured":"Maan A, Heist EK, Shaikh AY, Ruskin JN, Mansour M. Apixaban in patients with atrial fibrillation: a systematic review. J Atr Fibrillation. 2012, 5:499. 10.4022\/jafib.499","journal-title":"J Atr Fibrillation"},{"key":"ref19","article-title":"Flecainide","author":"Arunachalam K","year":"2025","unstructured":"Arunachalam K, Alzahrani T. Flecainide. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4022\/jafib.1268","article-title":"What does the blanking period blank?","volume":"8","author":"Mariani MA","year":"2015","unstructured":"Mariani MA, Pozzoli A, Maat G, Alfieri OR, Benussi S. What does the blanking period blank?. J Atr Fibrillation. 2015, 8:1268. 10.4022\/jafib.1268","journal-title":"J Atr Fibrillation"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2015.01.18","article-title":"Can oral anticoagulants be stopped safely after a successful atrial fibrillation ablation?","volume":"7","author":"Chao TF","year":"2015","unstructured":"Chao TF, Lin YJ, Chang SL, et al.. Can oral anticoagulants be stopped safely after a successful atrial fibrillation ablation?. J Thorac Dis. 2015, 7:172-7. 10.3978\/j.issn.2072-1439.2015.01.18","journal-title":"J Thorac Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/423217-a-case-of-atrial-fibrillation-and-rapid-ventricular-response-in-a-22-year-old-athlete-with-sickle-cell-trait","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T12:32:13Z","timestamp":1761481933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/423217-a-case-of-atrial-fibrillation-and-rapid-ventricular-response-in-a-22-year-old-athlete-with-sickle-cell-trait"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,26]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.95437","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,26]]}}}